Purine analog-like properties of bendamustine underlie rapid activation of DNA damage response and synergistic effects with pyrimidine analogues in lymphoid malignancies.

MLA

Nobuya Hiraoka, et al. “Purine Analog-like Properties of Bendamustine Underlie Rapid Activation of DNA Damage Response and Synergistic Effects with Pyrimidine Analogues in Lymphoid Malignancies.” PLoS ONE, vol. 9, no. 3, Jan. 2014, p. e90675. EBSCOhost, https://doi.org/10.1371/journal.pone.0090675.

APA

Nobuya Hiraoka, Jiro Kikuchi, Takahiro Yamauchi, Daisuke Koyama, Taeko Wada, Mitsuyo Uesawa, Miyuki Akutsu, Shigehisa Mori, Yuichi Nakamura, Takanori Ueda, Yasuhiko Kano, & Yusuke Furukawa. (2014). Purine analog-like properties of bendamustine underlie rapid activation of DNA damage response and synergistic effects with pyrimidine analogues in lymphoid malignancies. PLoS ONE, 9(3), e90675. https://doi.org/10.1371/journal.pone.0090675

Chicago

Nobuya Hiraoka, Jiro Kikuchi, Takahiro Yamauchi, Daisuke Koyama, Taeko Wada, Mitsuyo Uesawa, Miyuki Akutsu, et al. 2014. “Purine Analog-like Properties of Bendamustine Underlie Rapid Activation of DNA Damage Response and Synergistic Effects with Pyrimidine Analogues in Lymphoid Malignancies.” PLoS ONE 9 (3): e90675. doi:10.1371/journal.pone.0090675.